How to Buy Artemis Medicare Services Ltd Shares?
You can easily buy the stocks/shares of Artemis Medicare Services Ltd (ARTEMISMED) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Artemis Medicare Services Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of ARTEMISMED as on 15th May 2025 is ₹247.76What is the return on Artemis Medicare Services Ltd share?
The past returns of Artemis Medicare Services Ltd (ARTEMISMED) share are- Past 1 week: N/A
- Past 1 month: -94.76
- Past 3 months: 12.79
- Past 6 months: -21.11
- Past 1 year: 42.50
- Past 3 years: 513.14
- Past 5 years: 1351.26
What is the Dividend yield % on Artemis Medicare Services Ltd share?
The current dividend yield of Artemis Medicare Services Ltd (ARTEMISMED) is 0.17What is the Market Cap of Artemis Medicare Services Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Artemis Medicare Services Ltd (ARTEMISMED) is ₹3594.29Cr as of 15th May 2025What is the 52 Week High and Low of Artemis Medicare Services Ltd?
The 52-week high and low of Artemis Medicare Services Ltd (ARTEMISMED) is ₹350 and ₹172.10.What is the PE and PB ratio of Artemis Medicare Services Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Artemis Medicare Services Ltd are 43.50 and 7.90 respectively.Which sector does Artemis Medicare Services Ltd belong to?
Artemis Medicare Services Ltd (ARTEMISMED) belongs to the Industrials sector & Business Support Services sub-sector.What are the peers or stocks similar to Artemis Medicare Services Ltd?
The peers or stocks similar to Artemis Medicare Services Ltd are: and many others.Can't decide whether or not to buy Artemis Medicare Services Ltd?
Worry no more! Login to Tickertape and check out Artemis Medicare Services Ltd (ARTEMISMED) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Artemis Medicare Services Ltd?
The 52-week high and low of Artemis Medicare Services Ltd (ARTEMISMED) is ₹350 and ₹172.10.1. Test Stocks FAQ for Artemis Medicare Services Ltd Shares?
You can easily buy the stocks/shares of Artemis Medicare Services Ltd (ARTEMISMED) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Artemis Medicare Services Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of ARTEMISMED as on 15th May 2025 is ₹247.76
Artemis Medicare Services Ltd
ARTEMISMED Share Price
247.760.84% (-2.09)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
ARTEMISMED Performance & Key Metrics
ARTEMISMED Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 43.50 | 7.90 | 0.17% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.66 | 6.54 | 0.62% |
ARTEMISMED Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ARTEMISMED Company Profile
Artemis Medicare Services Ltd is headquartered in Gurgaon, Haryana, India and is a provider of administrative management and general management consulting services. The company was founded in 2009. PTL Enterprises Ltd is its ultimate parent.
KFINTECH
PE Ratio
62.45
62.45
1Y Return
67.82%
67.82%
Buy Reco %
—
—
INDGN
PE Ratio
35.33
35.33
1Y Return
0.15%
0.15%
Buy Reco %
—
—
RITES
PE Ratio
36.15
36.15
1Y Return
14.69%
14.69%
Buy Reco %
33.33
33.33
SIS
PE Ratio
453.27
453.27
1Y Return
15.94%
15.94%
Buy Reco %
83.33
83.33
PE Ratio
67.53
67.53
1Y Return
37.85%
37.85%
Buy Reco %
—
—
ARTEMISMED Sentiment Analysis
ARTEMISMED Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ARTEMISMED Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
ARTEMISMED Stock Growth Drivers
ARTEMISMED Stock Growth Drivers
5Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
ARTEMISMED Stock Challenges
ARTEMISMED Stock Challenges
4Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
ARTEMISMED Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
ARTEMISMED Forecasts
Price
Revenue
Earnings
ARTEMISMED Share Price Forecast
ARTEMISMED Share Price Forecast
2025
Current
₹259.05
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹259.05
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ARTEMISMED Company Revenue Forecast
ARTEMISMED Company Revenue Forecast
2025
Current
₹969.90
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹969.90
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
ARTEMISMED Stock EPS (Earnings Per Share) Forecast
ARTEMISMED Stock EPS (Earnings Per Share) Forecast
2025
Current
₹5.37
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹5.37
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ARTEMISMED
ARTEMISMED
Income
Balance Sheet
Cash Flow
Annual Normal View
ARTEMISMED Income Statement
ARTEMISMED Income Statement
Annual Normal View
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 550.52 | 569.62 | 415.17 | 558.70 | 744.77 | 885.92 | 969.90 | 969.91 | ||||||||
Raw Materials | 1.45 | 1.49 | 0.30 | 0.10 | 0.00 | 0.00 | 785.13 | 785.14 | ||||||||
| Power & Fuel Cost | 11.02 | 10.40 | 9.35 | 13.03 | 16.05 | 15.97 | ||||||||||
| Employee Cost | 97.28 | 103.42 | 83.99 | 104.30 | 120.78 | 138.95 | ||||||||||
| Selling & Administrative Expenses | 207.03 | 211.95 | 15.37 | 19.52 | 33.37 | 36.87 | ||||||||||
| Operating & Other expenses | 165.92 | 176.29 | 264.20 | 350.40 | 473.28 | 554.08 | ||||||||||
EBITDA | 67.82 | 66.07 | 41.96 | 71.35 | 101.29 | 140.05 | 184.77 | 184.77 | ||||||||
| Depreciation/Amortization | 20.07 | 22.63 | 21.51 | 22.19 | 31.00 | 40.32 | 45.16 | 45.16 | ||||||||
| PBIT | 47.75 | 43.44 | 20.45 | 49.16 | 70.29 | 99.73 | 139.61 | 139.61 | ||||||||
| Interest & Other Items | 11.00 | 12.80 | 12.93 | 11.98 | 19.68 | 31.29 | 31.94 | 31.94 | ||||||||
| PBT | 36.75 | 30.64 | 7.52 | 37.18 | 50.61 | 68.44 | 107.67 | 107.67 | ||||||||
| Taxes & Other Items | 16.26 | 10.84 | 1.04 | 5.37 | 12.01 | 19.31 | 25.04 | 25.04 | ||||||||
| Net Income | 20.49 | 19.80 | 6.48 | 31.81 | 38.60 | 49.13 | 82.63 | 82.63 | ||||||||
| EPS | 0.10 | 0.18 | 0.49 | 2.40 | 2.90 | 3.64 | 5.37 | 6.08 | ||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.45 | 0.45 | 0.45 | 0.45 | ||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 0.12 | 0.08 | 0.07 |
ARTEMISMED Company Updates
FY 2025FY 2025
Investor Presentation
May 12PDF
Feb 5PDF
Nov 15PDF
ARTEMISMED Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
ARTEMISMED Past Performance & Peer Comparison
ARTEMISMED Past Performance & Peer Comparison
Comparing 3 stocks from
IndustrialsBusiness Support Services
Compare valuation-basic on Screener
IndustrialsBusiness Support Services
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Artemis Medicare Services Ltd | 43.50 | 7.90 | 0.17% |
| Kfin Technologies Ltd | 62.45 | 18.20 | 0.62% |
| Indegene Ltd | 35.33 | 5.49 | 0.33% |
| RITES Ltd | 36.15 | 5.11 | 3.04% |
ARTEMISMED Stock Price Comparison
Compare ARTEMISMED with any stock or ETFCompare ARTEMISMED with any stock or ETF
ARTEMISMED
ARTEMISMED Holdings
ARTEMISMED Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
ARTEMISMED Promoter Holdings Trend
ARTEMISMED Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
Lower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
ARTEMISMED Institutional Holdings Trend
ARTEMISMED Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ARTEMISMED Shareholding Pattern
ARTEMISMED Shareholding Pattern
ARTEMISMED Shareholding History
ARTEMISMED Shareholding History
Foreign Institutions
Mutual Funds Invested in ARTEMISMED
Mutual Funds Invested in ARTEMISMED
No mutual funds holding trends are available
Top 5 Mutual Funds holding Artemis Medicare Services Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9262% | Percentage of the fund’s portfolio invested in the stock 2.10% | Change in the portfolio weight of the stock over the last 3 months 0.23% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 22/31 (+3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2591% | Percentage of the fund’s portfolio invested in the stock 1.80% | Change in the portfolio weight of the stock over the last 3 months 1.80% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/68 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1753% | Percentage of the fund’s portfolio invested in the stock 1.13% | Change in the portfolio weight of the stock over the last 3 months 0.39% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 31/66 (-1) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ARTEMISMED stock
smallcases containing ARTEMISMED stock
Looks like this stock is not in any smallcase yet.
ARTEMISMED Events
ARTEMISMED Events
ARTEMISMED Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
ARTEMISMED Dividend Trend
No dividend trend available
ARTEMISMED Upcoming Dividends
ARTEMISMED Upcoming Dividends
No upcoming dividends are available
ARTEMISMED Past Dividends
ARTEMISMED Past Dividends
Cash Dividend
Ex DateEx DateJul 5, 2024
Final
Final | Div/Share: ₹0.45
Dividend/Share
₹0.45
Ex DateEx Date
Jul 5, 2024
ARTEMISMED Stock News & Opinions
ARTEMISMED Stock News & Opinions
Articles & Videos
Earnings
Artemis Medicare Services consolidated net profit rises 62.41% in the March 2025 quarter
Net profit of Artemis Medicare Services rose 62.41% to Rs 23.03 crore in the quarter ended March 2025 as against Rs 14.18 crore during the previous quarter ended March 2024. Sales rose 6.51% to Rs 239.90 crore in the quarter ended March 2025 as against Rs 225.24 crore during the previous quarter ended March 2024. For the full year,net profit rose 68.15% to Rs 82.63 crore in the year ended March 2025 as against Rs 49.14 crore during the previous year ended March 2024. Sales rose 6.64% to Rs 936.92 crore in the year ended March 2025 as against Rs 878.57 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales239.90225.24 7 936.92878.57 7 OPM %14.9616.85 -16.2015.11 - PBDT40.4131.28 29 152.83108.77 41 PBT28.6620.24 42 107.6768.45 57 NP23.0314.18 62 82.6349.14 68 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Artemis Medicare Services recommends Final Dividend
Artemis Medicare Services announced that the Board of Directors of the Company at its meeting held on 12 May 2025, has recommended a Final Dividend of Rs.0.45 per share (i.e.45%), subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Artemis Medicare Services to conduct board meeting
Artemis Medicare Services will hold a meeting of the Board of Directors of the Company on 12 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Artemis Medicare Services consolidated net profit rises 78.96% in the December 2024 quarter
Net profit of Artemis Medicare Services rose 78.96% to Rs 20.67 crore in the quarter ended December 2024 as against Rs 11.55 crore during the previous quarter ended December 2023. Sales rose 6.22% to Rs 232.39 crore in the quarter ended December 2024 as against Rs 218.78 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales232.39218.78 6 OPM %16.1214.92 - PBDT38.2626.47 45 PBT26.8116.31 64 NP20.6711.55 79 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Artemis Medicare Services to convene board meeting
Artemis Medicare Services will hold a meeting of the Board of Directors of the Company on 5 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Artemis Medicare Services consolidated net profit rises 63.80% in the September 2024 quarter
Net profit of Artemis Medicare Services rose 63.80% to Rs 22.26 crore in the quarter ended September 2024 as against Rs 13.59 crore during the previous quarter ended September 2023. Sales rose 7.29% to Rs 241.42 crore in the quarter ended September 2024 as against Rs 225.01 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales241.42225.01 7 OPM %17.5015.20 - PBDT41.7328.75 45 PBT30.5518.80 63 NP22.2613.59 64 Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Artemis Medicare Services standalone net profit rises 63.83% in the September 2024 quarter
Net profit of Artemis Medicare Services rose 63.83% to Rs 22.56 crore in the quarter ended September 2024 as against Rs 13.77 crore during the previous quarter ended September 2023. Sales rose 8.19% to Rs 234.67 crore in the quarter ended September 2024 as against Rs 216.91 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales234.67216.91 8 OPM %17.8015.36 - PBDT41.6828.32 47 PBT31.0818.94 64 NP22.5613.77 64 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Artemis Medicare Services to hold board meeting
Artemis Medicare Services will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Artemis Medicare Services consolidated net profit rises 69.76% in the June 2024 quarter
Net profit of Artemis Medicare Services rose 69.76% to Rs 16.67 crore in the quarter ended June 2024 as against Rs 9.82 crore during the previous quarter ended June 2023. Sales rose 6.52% to Rs 223.20 crore in the quarter ended June 2024 as against Rs 209.54 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales223.20209.54 7 OPM %16.2113.31 - PBDT32.4422.28 46 PBT21.6413.11 65 NP16.679.82 70 Powered by Capital Market - Live
10 months agoCapital Market - Live
Artemis Medicare’s shares up 2% on strong quarterly results
1 year agoMoneycontrol
Over the last 5 years, revenue has grown at a yearly rate of 9.98%, vs industry avg of 11.51%
Over the last 5 years, market share decreased from 3.65% to 2.85%
Over the last 5 years, net income has grown at a yearly rate of 19.11%, vs industry avg of 20.56%